Total Payments
$52,887
2024 Payments
$2,093
Companies
1
Transactions
31
Payment Breakdown by Category
Travel$27,181 (51.4%)
Consulting$25,293 (47.8%)
Food & Beverage$345.51 (0.7%)
Research$67.93 (0.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $27,181 | 9 | 51.4% |
| Consulting Fee | $25,293 | 13 | 47.8% |
| Food and Beverage | $345.51 | 8 | 0.7% |
| Unspecified | $67.93 | 1 | 0.1% |
Payments by Type
General
$52,819
30 transactions
Research
$67.93
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $52,887 | 31 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,093 | 3 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($2,093) |
| 2023 | $12,495 | 7 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($12,495) |
| 2022 | $5,812 | 2 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($5,812) |
| 2021 | $534.03 | 5 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($534.03) |
| 2020 | $6,890 | 5 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($6,890) |
| 2018 | $25,063 | 9 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($25,063) |
All Payment Transactions
31 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | TOLVAPTAN (Drug) | Consulting Fee | Cash or cash equivalent | $975.00 | General |
| Category: NEPHROLOGY | ||||||
| 10/25/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | TOLVAPTAN (Drug) | — | In-kind items and services | $67.93 | Research |
| Study: A PHASE 3B MULTICENTER OPEN-LABEL TRIAL OF THE SAFETY, TOLERABILITY, AND EFFICACY OF TOLVAPTAN IN INFANTS AND CHILDREN 28 DAYS TO LESS THAN 12 WEEKS OF AGE WITH AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE (ARPKD) • Category: NEPHROLOGY | ||||||
| 08/12/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | TOLVAPTAN (Drug) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: NEPHROLOGY | ||||||
| 12/19/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | TOLVAPTAN (Drug) | Consulting Fee | Cash or cash equivalent | $1,650.00 | General |
| Category: NEPHROLOGY | ||||||
| 12/11/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | TOLVAPTAN (Drug) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: NEPHROLOGY | ||||||
| 06/16/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | TOLVAPTAN (Drug) | Travel and Lodging | In-kind items and services | $436.58 | General |
| Category: NEPHROLOGY | ||||||
| 06/16/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | TOLVAPTAN (Drug) | Travel and Lodging | In-kind items and services | $252.85 | General |
| Category: NEPHROLOGY | ||||||
| 06/15/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | TOLVAPTAN (Drug) | Travel and Lodging | In-kind items and services | $9,238.84 | General |
| Category: NEPHROLOGY | ||||||
| 06/15/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | TOLVAPTAN (Drug) | Travel and Lodging | In-kind items and services | $252.85 | General |
| Category: NEPHROLOGY | ||||||
| 06/15/2023 | Otsuka Pharmaceutical Development & Commercialization, Inc. | TOLVAPTAN (Drug) | Food and Beverage | In-kind items and services | $63.56 | General |
| Category: NEPHROLOGY | ||||||
| 10/21/2022 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 01/19/2022 | Otsuka Pharmaceutical Development & Commercialization, Inc. | TOLVAPTAN (Drug) | Consulting Fee | Cash or cash equivalent | $4,312.00 | General |
| Category: NEPHROLOGY | ||||||
| 12/17/2021 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Travel and Lodging | In-kind items and services | $439.01 | General |
| 12/17/2021 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $37.02 | General |
| 12/17/2021 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $29.67 | General |
| 12/17/2021 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $18.33 | General |
| 12/17/2021 | Otsuka Pharmaceutical Development & Commercialization, Inc. | — | Food and Beverage | In-kind items and services | $10.00 | General |
| 11/03/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | JYNARQUE (Drug) | Consulting Fee | Cash or cash equivalent | $2,550.00 | General |
| Category: NEPHROLOGY | ||||||
| 11/03/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | JYNARQUE (Drug) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: NEPHROLOGY | ||||||
| 11/03/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | JYNARQUE (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: NEPHROLOGY | ||||||
| 10/29/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | JYNARQUE (Drug) | Consulting Fee | Cash or cash equivalent | $440.00 | General |
| Category: NEPHROLOGY | ||||||
| 10/28/2020 | Otsuka Pharmaceutical Development & Commercialization, Inc. | JYNARQUE (Drug) | Consulting Fee | Cash or cash equivalent | $1,200.00 | General |
| Category: NEPHROLOGY | ||||||
| 11/14/2018 | Otsuka Pharmaceutical Development & Commercialization, Inc. | TOLVAPTAN (Drug) | Consulting Fee | Cash or cash equivalent | $4,664.00 | General |
| Category: NEPHROLOGY | ||||||
| 09/25/2018 | Otsuka Pharmaceutical Development & Commercialization, Inc. | TOLVAPTAN (Drug) | Travel and Lodging | In-kind items and services | $8,999.11 | General |
| Category: NEPHROLOGY | ||||||
| 09/25/2018 | Otsuka Pharmaceutical Development & Commercialization, Inc. | TOLVAPTAN (Drug) | Travel and Lodging | In-kind items and services | $845.02 | General |
| Category: NEPHROLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 3B MULTICENTER OPEN-LABEL TRIAL OF THE SAFETY, TOLERABILITY, AND EFFICACY OF TOLVAPTAN IN INFANTS AND CHILDREN 28 DAYS TO LESS THAN 12 WEEKS OF AGE WITH AUTOSOMAL RECESSIVE POLYCYSTIC KIDNEY DISEASE (ARPKD) | Otsuka Pharmaceutical Development & Commercialization, Inc. | $67.93 | 1 |
About Dr. Lisa Guay-Woodford, MD
Dr. Lisa Guay-Woodford, MD is a Pediatric Nephrology healthcare provider based in Washington, District of Columbia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538178421.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lisa Guay-Woodford, MD has received a total of $52,887 in payments from pharmaceutical and medical device companies, with $2,093 received in 2024. These payments were reported across 31 transactions from 1 company. The most common payment nature is "Travel and Lodging" ($27,181).
Ad
Practice Information
- Specialty Pediatric Nephrology
- Location Washington, DC
- Active Since 08/07/2006
- Last Updated 10/25/2012
- Taxonomy Code 2080P0210X
- Entity Type Individual
- NPI Number 1538178421
Products in Payments
- TOLVAPTAN (Drug) $37,177
- JYNARQUE (Drug) $6,890
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Nephrology Doctors in Washington
Marva Moxey-Mims, Md, MD
Pediatric Nephrology — Payments: $8,989
Pediatric Nephrology $8,989
Asha Moudgil, Md, MD
Pediatric Nephrology — Payments: $4,840
Pediatric Nephrology $4,840
Denver Brown, Md, MD
Pediatric Nephrology — Payments: $353.28
Pediatric Nephrology $353.28
Celina Brunson
Pediatric Nephrology — Payments: $300.95
Pediatric Nephrology $300.95
Sarah Rogal, Md Mph, MD MPH
Pediatric Nephrology — Payments: $48.78
Pediatric Nephrology $48.78
Anuradha Gajjar, M.d, M.D
Pediatric Nephrology — Payments: $15.77
Pediatric Nephrology $15.77